Skip to main content
SpringerLink
Log in

Ipilimumab/nivolumab

Hepatitis B: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Koksal AS, et al. HBV-related acute hepatitis due to immune checkpoint inhibitors in a patient with malignant melanoma. Annals of Oncology 28: 3103-3104, No. 12, 1 Dec 2017. Available from: URL: http://doi.org/10.1093/annonc/mdx502 - Turkey

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ipilimumab/nivolumab. Reactions Weekly 1694, 239 (2018). https://doi.org/10.1007/s40278-018-43640-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-43640-4

Search

Navigation